Clinical Updates

May 2020 Release of the Carlisle Drug Reference Guide
May 2020 Release of the Carlisle Drug Reference Guide

The latest release of the Carlisle Drug Reference Guide provides a list of frequently prescribed…

May 14, 2020
Nurtec ODT
Nurtec ODT is now Available for the Acute Treatment of Acute Migraine

Nurtec ODT, rimegepant orally disintegrating tablet, is now available for the acute treatment of acute…

Apr 16, 2020
Removal of Ranitidine from Market
Removal of Ranitidine from Market

The Food and Drug Administration (FDA) recently announced a request for manufacturers to remove all…

Apr 15, 2020
First-Time Generic Release of Vimovo
First-Time Generic Release of Vimovo

The generic equivalent of Vimovo (naproxen/esomeprazole) is now available. Vimovo is FDA approved for the…

Mar 09, 2020
Monitoring Coronavirus Concerns - Carlisle Medical
Carlisle Medical Monitoring Coronavirus Concerns

Carlisle Medical continues to monitor concerns for potential disruptions in the availability of medications and…

Mar 06, 2020
FDA Approves Three Drugs for OTC Use
FDA Approves Three Drugs for OTC Use

Last week, the FDA approved three medications for over-the-counter (OTC) use through a process called…

Mar 02, 2020
Generic Zohydro Is Now Available
Generic Zohydro Is Now Available

The generic formulation of Zohydro, hydrocodone bitartrate ER, has been released by Macoven Pharmaceuticals. Zohydro…

Jan 30, 2020
December 2019 Generic Drug Update
Generic Drug Update

Launch of Generic Travatan Z A generic is now available for the ophthalmic drug Travatan…

Dec 31, 2019
FDA Approves New Migraine Treatments
FDA Approves New Migraine Treatments

Two new medications for the treatment of acute migraine with or without aura in adults…

Dec 30, 2019
FDA Releases Warning Regarding Gabapentin and Pregabalin
FDA Releases Warning Regarding Gabapentin and Pregabalin

The FDA recently released a warning for the medications, gabapentin (Neurontin, Gralise, Horizant) and pregabalin…

Dec 23, 2019
  • This field is for validation purposes and should be left unchanged.


Filter Articles

Should a claimant need this much pain medication for this long? Are claimants utilizing medications or selling on the black market?

The prevalence of opioid use and abuse among those with chronic pain has developed into one of the most pressing issues today. Download the white paper to learn facts about the opioid crisis and possible solutions to avoid prescriptions that could lead to abuse.

Download Now